Żołnierek, J. 2023. The first line therapy for intermediate/ high risk patients with advanced renal cell carcinoma according to therapeutic program B.10. OncoReview. 13, 2(50) (Aug. 2023), 48-57. DOI:https://doi.org/10.24292/01.OR.132190823.